Improving functional outcomes for schizophrenia patients in the Netherlands using Cognitive Adaptation Training as a nursing intervention - A pilot study

Schizophrenia Research

Volumn 158, Issue 1-3, 2014, Pages 120-125

  Quee, Piotr J ^a,b   Stiekema, Annemarie P M ^a,b   Wigman, Johanna T W ^a   Schneider, Harald ^b   van der Meer, Lisette ^a,b   Maples, Natalie J ^c   van den Heuvel, Edwin R ^a   Velligan, Dawn I ^c   Bruggeman, Richard ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b Department of Rehabilitation Lentis Center for Mental Health ^*  (Netherlands)

^c Division of Schizophrenia and Related Disorders Department of Psychiatry University of TX at San Antonio   (United States)

Author keywords

CAT; Cognition; Compensation; Rehabilitation; Schizophrenia; Treatment

Indexed keywords

ADULT; ARTICLE; CLINICAL ARTICLE; COGNITIVE ADAPTATION TRAINING; COGNITIVE THERAPY; COHORT ANALYSIS; COMPARATIVE EFFECTIVENESS; COMPARATIVE STUDY; CONTROLLED STUDY; FEASIBILITY STUDY; FEMALE; HOSPITAL PATIENT; HUMAN; MALE; MULTNOMAH COMMUNITY ABILITY SCALE; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; NEGATIVE SYMPTOM ASSESSMENT MOTIVATION SUBSCALE; NETHERLANDS; NURSE; NURSING INTERVENTION; OUTCOME ASSESSMENT; PILOT STUDY; PRIORITY JOURNAL; PSYCHIATRIC NURSE; PSYCHOLOGIST; RANDOMIZED CONTROLLED TRIAL; SCHIZOPHRENIA; SOCIAL AND OCCUPATIONAL FUNCTIONING SCALE; TREATMENT DURATION; HOME CARE; HOSPITALIZATION; MIDDLE AGED; NURSING CARE; PROCEDURES; PSYCHOLOGICAL RATING SCALE; TREATMENT OUTCOME;

NEUROLEPTIC AGENT;

ADULT; ANTIPSYCHOTIC AGENTS; COGNITIVE THERAPY; FEASIBILITY STUDIES; FEMALE; HOME CARE SERVICES; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; NETHERLANDS; NURSING CARE; PILOT PROJECTS; PSYCHIATRIC STATUS RATING SCALES; SCHIZOPHRENIA; TREATMENT OUTCOME;

EID: 84924412664     PISSN: 09209964     EISSN: 15732509     Source Type: Journal    
DOI: 10.1016/j.schres.2014.06.020     Document Type: Article

References (27)

1. Alphs L.D., Summerfelt A., Lann H., Muller R.J. The negative symptom assessment: a new instrument to assess negative symptoms of schizophrenia. Psychopharmacol. Bull. 1989, 25(2):159-163.
2. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders 2000, American Psychiatric Publishing, Washington, DC, (DSM-IV-TR). fourth ed.
3. Andreasen N.C., Pressler M., Nopoulos P., Miller D., Ho B.C. Antipsychotic dose equivalents and dose-years: a standardized method for comparing exposure to different drugs. Biol. Psychiatry 2010, 67(3):255-262.
4. Barker S., Barron N., McFarland B.H., Bigelow D.A. A Community Ability Scale for chronically mentally ill consumers: part I: reliability and validity. Community Ment. Health J. 1994, 30(4):363-383.
5. College voor Zorgverzekeringen (CVZ) Farmaceutisch Kompas 2008, Bohn Stafleu van Loghum, Houten, The Netherlands.
6. Goldman H.H., Skodol A.E., Lave T.R. Revising axis V for DSM-IV: a review of measures of social functioning. Am. J. Psychiatr. 1992, 149(9):1148-1156.
7. Hansen J.P., Østergaard B., Nordentoft M., Hounsgaard L. Cognitive adaptation training combined with assertive community treatment: a randomised longitudinal trial. Schizophr. Res. 2012, 135(1-3):105-111.
8. Kay S.R., Fiszbein A., Opler L.A. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr. Bull. 1987, 13(2):261-276.
9. Keefe R.S., Bilder R.M., Davis S.M., et al. Neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE Trial. Arch. Gen. Psychiatry 2007, 64(6):633-647.
10. Leucht S., Corves C., Arbter D., Engel R.R., Li C., Davis J.M. Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis. Lancet 2009, 373(9657):31-41.
11. McGurk S.R., Twamley E.W., Sitzer D.I., McHugo G.J., Mueser K.T. A meta-analysis of cognitive remediation in schizophrenia. Am. J. Psychiatry 2007, 164(12):1791-1802.
12. Nelson H.E. A modified card sorting test sensitive to frontal lobe defects. Cortex 1976, 12(4):313-324.
13. Onken S.J., Dumont J.M., Ridgway P., Dornan D.H., Ralph R.O., Onken S.J., Dumont J.M., Ridgway P., Dornan D.H., Ralph R.O. Mental health recovery: what helps and what hinders? A national research project for the development of recovery facilitating system performance indicators. Phase One Research Report: A National Study of Consumer Perspectives on What Helps and Hinders Mental Health Recovery 2002, NASMHPD, National Technical Assistance Center (NTAC), Alexandria, VA.
14. Palmer B.W., Dawes S.E., Heaton R.K. What do we know about neuropsychological aspects of schizophrenia?. Neuropsychol. Rev. 2009, 19(3):365-384.
15. Quee P.J., Schneider H., van Slogteren S., Wiersma D., Bruggeman R., Velligan D.I. Cognitive adaptation training provided to chronically hospitalized patients with schizophrenia in the Netherlands: two case reports. Case Rep. Psychiatry 2012, 2012:596162.
16. Quee P.J., Wiersma D., Sytema S., Bruggeman R. Cognitive adaptation training combined with assertive community treatment: a randomised longitudinal trial-a comment. Schizophr. Res. 2012, 140(1-3):264-265.
17. Schmand B., Groenink S.C., van den Dungen M. Letterfluency: Psychometrische eigenschappen en Nederlandse normen (Dutch). Tijdschr. Gerontol. Geriatr. 2008, 39(2):64-76.
18. Stout J.C., Ready R.E., Grace J., Malloy P.F., Paulsen J.S. Factor analysis of the Frontal Systems Behavior Scale (FrSBe). Assessment 2003, 10(1):79-85.
19. Uggerby P., Nielsen R.E., Correll C.U., Nielsen J. Characteristics and predictors of long-term institutionalization in patients with schizophrenia. Schizophr. Res. 2011, 131(1-3):120-126.
20. Velligan D.I., Bow-Thomas C.C., Huntzinger C., et al. Randomized controlled trial of the use of compensatory strategies to enhance adaptive functioning in outpatients with schizophrenia. Am. J. Psychiatry 2000, 157(8):1317-1323.
21. Velligan D.I., Prihoda T.J., Ritch J.L., Maples N., Bow-Thomas C.C., Dassori A. A randomized single-blind pilot study of compensatory strategies in schizophrenia outpatients. Schizophr. Bull. 2002, 28(2):283-292.
22. Velligan D.I., Diamond P.M., Maples N.J., et al. Comparing the efficacy of interventions that use environmental supports to improve outcomes in patients with schizophrenia. Schizophr. Res. 2008, 102(1-3):312-219.
23. Velligan D.I., Diamond P.M., Mintz J., et al. The use of individually tailored environmental supports to improve medication adherence and outcomes in schizophrenia. Schizophr. Bull. 2008, 34(3):483-493.
24. Velligan D.I., Maples N.J., Ritch J.L. Cognitive Adaptation Training: The Use of Compensatory Strategies in the Psychosocial Rehabilitation of Patients With Schizophrenia (Manual) 2010, UTHSCSA, Department of Psychiatry, San Antonio, TX.
25. Wiersma D., Pijl Y.J. Langverblijvers in de psychiatrie. Een epidemiologische beschouwing over hun omvang en samenstelling (Dutch). Tijdschrift voor rehabilitatie en herstel van mensen met psychische beperkingen 2008, 4-12.
26. Wolthaus J.E., Dingemans P.M., Schene A.H., Linszen D.H., Knegtering H., Holthausen E.A., Cahn W., Hijman R. Component structure of the positive and negative syndrome scale (PANSS) in patients with recent onset schizophrenia and spectrum disorders. Psychopharmacology 2000, 150:399-403.
27. Wykes T., Spaulding W.D. Thinking about the future cognitive remediation therapy-what works and could we do better?. Schizophr. Bull. 2011, 37(Suppl. 2):S80-S90.